Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
M
|
ManpowerGroup Inc
XMUN:MPW
|
US |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
US |
|
BRP Inc
TSX:DOO
|
CA |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
SSR Mining Inc
NASDAQ:SSRM
|
CA |
|
T
|
Technip Energies NV
OTC:THNPY
|
FR |
|
First Mining Gold Corp
TSX:FF
|
CA |
|
Magna International Inc
TSX:MG
|
CA |
|
KHD Humboldt Wedag Vermoegensverwaltungs-AG
F:HETA
|
DE |
|
Braemar Shipping Services PLC
LSE:BMS
|
UK |
|
Tubacex SA
MAD:TUB
|
ES |
|
MongoDB Inc
NASDAQ:MDB
|
US |
|
Aperam SA
OTC:APMSF
|
LU |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
Itochu Corp
F:IOC0
|
JP |
|
Rewalk Robotics Ltd
NASDAQ:LFWD
|
IL |
|
C
|
CNOOC Ltd
TSX:CNU
|
CN |
|
D
|
Desert Control AS
OSE:DSRT
|
NO |
|
V
|
Valeo SE
F:VSA
|
FR |
|
F
|
First Quantum Minerals Ltd
F:IZ1
|
CA |
|
B
|
Banco de Sabadell SA
DUS:BDSB
|
ES |
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
FR |
Wall St Price Targets
Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 20.91 CNY with a low forecast of 12.63 CNY and a high forecast of 27.17 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shanghai Pharmaceuticals Holding Co Ltd's stock price target?
Price Target
20.91
CNY
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 20.91 CNY with a low forecast of 12.63 CNY and a high forecast of 27.17 CNY.
What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 5%.
